The study shows the feasibility and potential efficacy of remotely delivered ILED and CLED programmes for weight loss and HbA1c reduction, and the feasibility of a randomized controlled trial comparing the two approaches. Mean (95% confidence interval) changes in the T2D medication effect score were 0.0008 (−0.3, 0.3) for ILED and −0.5 (−0.8, −0.3) for CLED. HbA1c <48 mmol/mol was achieved in 42% of both groups. The participants log their eating habits and activities via the programme, receive three motivational messages from the app per day and complete a total of 22. Intention-to-treat analysis at 52 weeks showed percentage weight loss was mean (95% confidence interval) −5.4% (−7.6, −3.1%) for ILED and −6.0% (−7.9, −4.0%) for CLED. The Excel sheet was developed on the basis of a pilot app assessment exercise with. Dia Amalindah, Agnestria Winarto, Anggun Hidayatur. Smartphone Apps for Diabetes Medication Adherence: Systematic Review.
Eighty-nine per cent (70 of 79) started using the app and 86% (44 of 51) still used the app at 52 weeks. Effectiveness of Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review. We enrolled 39 ILED and 40 CLED participants and 27 (69%) ILED and 30 CLED (75%) attended the 52-week follow-up. Feasibility outcomes included study uptake, retention, app usage, dietary adherence, weight loss and change in glycated haemoglobin (HbA1c) at 52 weeks. Both groups received frequent telephone or the Oviva app support. Customer Reviews 'The best app I have used for tracking all the things we need to track for diabetes.' 'Having used a variety of data storage systems I find that this is as near perfect as one could wish for.' 'The database of foods is huge, the reports are solid and the user experience is clean and simple. Every T1d and their caregiver or friends should have this app. I don’t want to miss a single step while trying not to panic. Weight maintenance/continued weight loss was undertaken for the remainder of the 52 weeks. Glucagon Review: 4 out of 5 stars As a parent of a 2yr old T1d, this app is a must I’ve watched the tutorial in case she ever has a severe hypo. Seventy-nine adults with overweight/obesity and T2D (≤8 years duration) were randomized 1:1 to CLED (8 weeks/56 days of daily Optifast 820 kcal (3430 kJ) diet) or isoenergetic ILED (2 days of Optifast and 5 days of a Mediterranean diet/week for 28 weeks). To test the feasibility and potential efficacy of remotely supported intermittent low-energy diets (ILEDs) and continuous low-energy diets (CLEDs) in people with type 2 diabetes (T2D) and the feasibility of a randomized controlled trial comparing the two approaches.
0 kommentar(er)
